Nyt fra tidsskrifterne
Søgeord (paxlovid) valgt.
17 emner vises.
1
D-dimer for efficacy prediction in COVID-19 patients treated with paxlovid
BMC Infectious Diseases
Tilføjet 26.11.2024
2
Who Needs Paxlovid in 2024?
Journal of the American Medical Association
Tilføjet 6.10.2024
3
Paxlovid reduces the 28-day mortality of patients with COVID-19: a retrospective cohort study
BMC Infectious Diseases
Tilføjet 6.08.2024
4
What the Latest Research Says About Paxlovid
Journal of the American Medical Association
Tilføjet 21.02.2024
5
Does Paxlovid Prevent Long COVID?
Journal of the American Medical Association
Tilføjet 12.01.2024
6
Azvudine versus paxlovid for oral treatment of COVID-19 in Chinese patients
BMC Infectious Diseases
Tilføjet 4.01.2024
7
Appraisal of evidence reliability and applicability of Paxlovid as treatment for SARS‐COV‐2 infection: A systematic review
Reviews in Medical Virology
Tilføjet 11.11.2023
8
Efficacy and safety of paxlovid (nirmatrelvir/ritonavir) in the treatment of COVID‐19: An updated meta‐analysis and trial sequential analysis
Reviews in Medical Virology
Tilføjet 8.09.2023
9
Soluble wild-type ACE2 molecules inhibit newer SARS-CoV-2 variants and are a potential antiviral strategy to mitigate disease severity in COVID-19
Clinical & Experimental Immunology
Tilføjet 11.08.2023
10
Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease
BMJ Open
Tilføjet 8.08.2023
11
Paxlovid reduces the risk of Long COVID in patients six months after hospital discharge
Journal of Medical Virology
Tilføjet 1.08.2023
12
Oral Nirmatrelvir and Ritonavir for Covid-19 in Vaccinated, Non-Hospitalized Adults, Ages 18-50 Years
Clinical Infectious Diseases
Tilføjet 2.07.2023
13
FDA Grants Full Approval to Paxlovid, COVID-19 Antiviral Treatment
Journal of the American Medical Association
Tilføjet 28.06.2023
14
A mathematical model of SARS‐CoV‐2 immunity predicts paxlovid rebound
Journal of Medical Virology
Tilføjet 8.06.2023
15
Paxlovid Alternative Is Similarly Effective
Journal of the American Medical Association
Tilføjet 1.03.2023
16
Getting Treated for COVID-19 Shouldn’t Be This Difficult
Journal of the American Medical Association
Tilføjet 11.01.2023
17
Early administration of Paxlovid reduces the viral elimination time in patients infected with SARS‐CoV‐2 omicron variants
Journal of Medical Virology
Tilføjet 30.12.2022